Identification of a Wnt/ Beta-catenin responsive adult lung epithelial progenitor cell for tissue repair in chronic lung disease
鉴定用于慢性肺病组织修复的 Wnt/β-连环蛋白反应性成人肺上皮祖细胞
基本信息
- 批准号:10001340
- 负责人:
- 金额:$ 6.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAcute Lung InjuryAddressAdultAffectAlveolarApplications GrantsBiological AssayBiologyCell LineageCell physiologyCellsChronicChronic Obstructive Airway DiseaseChronic lung diseaseCigarette smoke-induced emphysemaDataDiseaseDistalEpithelialEpithelial CellsEpitheliumExhibitsFlow CytometryFoundationsFutureGenesGoalsHumanImpairmentIn SituIn VitroInflammationInjuryKnowledgeLungMedicineModelingMolecularMusNatural regenerationOrganOrganoidsOxidative StressPathway interactionsPatientsPhenotypePopulationPulmonary EmphysemaPulmonary PathologyReporterResearchResearch PersonnelRoleSignal PathwaySignal TransductionSolidStainsStructure of parenchyma of lungTACSTD1 geneTestingTissuesTrainingTransgenic MiceTransgenic OrganismsVariantWorkbeta catenincareercell typecigarette smoke-inducedclinical phenotypeepithelial stem cellin vivo Modellung injurylung regenerationmouse modelnovelnovel markernovel strategiesnovel therapeutic interventionprogenitorregenerativeregenerative therapyrepairedresponseskillsstem cellstissue culturetissue regenerationtissue repairtranscriptometranslational scientist
项目摘要
Project Summary/Abstract
The goal of this proposal is to determine the potential of endogenous epithelial progenitor cells to contribute to
regenerative approaches for emphysema therapies. Emphysema is a major phenotype of chronic obstructive
lung disease (COPD) and affects over 4 million people in the US. It is characterized by progressive loss of
alveolar lung tissue without therapies that stop or reverse the disease. Importantly, the endogenous ability of the
distal lung to activate self-repair mechanisms is defective in emphysema, raising the question why and which
regenerative pathways and/or cells are silenced in emphysema. WNT/beta-catenin signaling has been recently
identified as a potential regenerative pathway with reduced activity in emphysema and re-activation of WNT/beta-
catenin signaling has been shown to initiate intrinsic lung tissue repair. However, the mechanisms and the
identity of potential progenitor cells that respond to WNT/β-catenin signaling and contribute to the repair of tissue
destruction in chronic lung diseases, remain unknown. My preliminary studies using transgenic Wnt/beta-catenin
activity reporter mice and a progenitor cell derived 3D lung organoid assay have identified a unique lung epithelial
population which forms airway and alveolar organoids and exhibits high sensitivity to the modulations of
WNT/beta-catenin signaling, thus representing a WNT/beta-catenin responsive progenitor population. Further,
population and single cell transcriptome analysis has led to the identification of an airway club cell progenitor
population as the major cell type in the WNT/beta-catenin responsive population. Thus, the aim of this proposal
is to address the central hypothesis that WNT/beta-catenin signaling activates club cells to regenerate alveolar
tissue in the emphysematous lung. This hypothesis will be tested in 3 Specific Aims: 1). Test the hypothesis that
the club cell population is WNT/beta-catenin responsive and forms organoids; 2). Determine the fate and
phenotype of the club cell population in murine emphysema models in vivo and their regenerative capacity upon
WNT/beta-catenin activation; 3). Test the hypothesis that the club cell population respond to WNT/beta-catenin
activation in human emphysematous lung tissue.
The proposed work will solve an existing challenge by defining a precise WNT/beta-catenin-responsive club cell
population in both mouse and human lungs and by identifying novel marker genes allowing to elucidate their
alterations and regenerative potential in emphysema. This work and the integrated training plan will allow the
investigator to establish comprehensive knowledge on lung injury and regeneration and expertise and skills to
subsequently define the molecular mechanism leading to successful lung tissue regeneration in a future
independent research career.
项目总结/摘要
这项提议的目的是确定内源性上皮祖细胞的潜力,
肺气肿治疗的再生方法。肺气肿是慢性阻塞性肺疾病的主要表型,
肺疾病(COPD),影响美国超过400万人。它的特点是逐渐丧失
肺泡肺组织没有治疗,停止或扭转疾病。重要的是,
远端肺激活自我修复机制是有缺陷的肺气肿,提出了一个问题,为什么和
再生途径和/或细胞在肺气肿中被沉默。WNT/β-连环蛋白信号传导最近被
被确定为一种潜在的再生途径,在肺气肿中活性降低,WNT/β-
已显示连环蛋白信号传导启动内在肺组织修复。然而,这些机制和
响应WNT/β-连环蛋白信号传导并有助于组织修复的潜在祖细胞的鉴定
慢性肺部疾病的破坏,仍然未知。我使用转基因Wnt/β-catenin的初步研究
活性报告小鼠和祖细胞衍生的3D肺类器官测定已经鉴定出独特的肺上皮细胞
形成气道和肺泡类器官并对以下调节表现出高敏感性的群体:
WNT/β-连环蛋白信号传导,因此代表WNT/β-连环蛋白应答性祖细胞群体。此外,本发明还
群体和单细胞转录组分析已经导致了气道俱乐部细胞祖细胞的鉴定
在WNT/β-连环蛋白应答性群体中,作为主要细胞类型的细胞群。因此,本提案的目的
是为了解决WNT/β-连环蛋白信号激活俱乐部细胞再生肺泡的中心假设,
肺气肿的肺组织该假设将在3个特定目标中进行检验:1)。测试的假设
俱乐部细胞群是WNT/β-连环蛋白应答性的并形成类器官; 2)。决定命运,
小鼠肺气肿模型中俱乐部细胞群的体内表型和它们的再生能力
WNT/β-连环蛋白激活; 3).检验俱乐部细胞群对WNT/β-连环蛋白应答的假设
在人肺气肿肺组织中的激活。
拟议的工作将通过定义精确的WNT/β-连环蛋白反应俱乐部细胞来解决现有的挑战
小鼠和人肺部中的细胞群,并通过鉴定新的标记基因来阐明它们的表达。
改变和再生潜力。这项工作和综合培训计划将使
研究者建立关于肺损伤和再生的全面知识,
随后确定导致未来成功肺组织再生的分子机制
独立的研究生涯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yan Hu其他文献
Yan Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yan Hu', 18)}}的其他基金
Molecular Analysis of Airway Secretory Cells in Health and Disease
健康和疾病中气道分泌细胞的分子分析
- 批准号:
10592181 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Identification of a Wnt/ Beta-catenin responsive adult lung epithelial progenitor cell for tissue repair in chronic lung disease
鉴定用于慢性肺病组织修复的 Wnt/β-连环蛋白反应性成人肺上皮祖细胞
- 批准号:
10231191 - 财政年份:2019
- 资助金额:
$ 6.93万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 6.93万 - 项目类别:
Fellowship